Vascular dementia

Vascular dementia

Vascular dementia, also known as multi-infarct dementia (MID) and vascular cognitive impairment (VCI), is dementia caused by problems in the supply of blood to the brain, typically by a series of minor strokes. Vascular dementia is the second most common form of dementia after Alzheimer’s disease in older adults. Early detection and accurate diagnosis are important, as vascular dementia is at least partially preventable and treatable.

Signs and symptoms

Dementias present similarly to one another and are very difficult to differentiate clinically. Patients suffering from Vascular dementia present with cognitive impairment, usually following one or many strokes. The symptoms may progress gradually or step-wise after each small stroke. Some people may appear to improve between events and decline after more silent strokes.

Vascular Dementia and Depression

Vascular dementia peaks between the 4th and the 7th decades of life and 80% of patients will have a history of elevated blood pressure. Vascular dementia patients develop progressive cognitive, motor and behavioral signs and symptoms and tend to have better free recall compared with Alzheimer’s disease patients but significant deficits in planning and execution of various tasks. Many patients also develop mood symptoms such as depression and if the frontal lobes are affected, which is often the case, patients may present as apathetic. This is often accompanied by problems with attention, orientation and urinary incontinence.

Causes

Risk factors for vascular dementia include age, hypertension, smoking, lack of exercise, elevated blood cholesterol, diabetes mellitus, cardiovascular disease, and cerebrovascular disease. Other risk factors include a person’s geographic origin (the disease is more common in Asian countries), genetic predisposition, and prior strokes.

Treatment

The goal of treatment is the prevention of further cerebrovascular lesions. Studies now convincingly show that treatment of elevated blood pressure can slow or stop the progression of vascular dementia.

Important points

Cholinesterase inhibitors such as Donepezil, Rivastigmine, Galantamine that are prescribed for Alzheimer’s disease have not shown to be helpful for Vascular dementia and could be even harmful by interfering with the cardiovascular function.
Behavioral and mood symptoms are particularly important in this patient group and tend to be resistant to conventional antidepressant medications, which could lead to hospital admission and placement in permanent care.

Treatment of elevated blood pressure can slow disease progression

As with most medical conditions, a timely evaluation by a physician specializing in diagnosis and treatment of memory disorders is the best approach to assuring the optimal outcome of a memory problem.

    
     
   

Questions? Send us an email!

PRIVACY. By filling out this form you agree to be contacted. If you do not wish to be contacted, please do not fill out this form. Filling out this form is not required in order to browse this website. Information that you provide to us will be used only for the purpose of contacting you. It will not be used for any other purpose and will not be sold to or shared with any third party. It will be irretrievably deleted if upon contacting you we will not hear back within 7 days. You may request to delete the information you provided at any time by filling this form again and indicating that you wish to have your information deleted. We will comply with your request within 48 hours upon receiving your message. 
Type your email address here
Type a brief message
 

© 2018 MoodNote LLC All Rights Reserved


            

            

                        
            
            
assignment_turned_in Registrations

    
     
   
This Form has no fields.
Please login to view this page.
Please login to view this page.
Please login to view this page.
Verified by MonsterInsights